Global Health Grant Opportunity

Grants up to $6 million to support organisations improve the understanding of infections in hospitals that drive antimicrobial resistance and develop interventions to reduce infections.

Current status of program

CLOSED

To register your interest in future rounds or discuss alternative grant opportunities please contact us here.

What is the Global Health Grant Opportunity (GHGO)?

The Global Health Grant Opportunity (GHGO) was announced as part of the Medical Research Future Fund under the Global Health Initiative.

The MRFF, established under the Medical Research Future Fund Act 2015 (MRFF Act), provides grants of financial assistance to support health and medical research and innovation to improve the health and wellbeing of Australians.

The Global Health Initiative (the Initiative) forms part of the MRFF. The Australian Government has announced a total of $30 million over 10 years from 2022-23 for the Initiative.

Healthcare-associated infections are infections that are acquired as a direct result of healthcare and are the most common complications affecting patients in hospital. Healthcare-associated infections greatly increase morbidity and mortality, prolong a patient’s hospital stay and increase the risk of readmission within 12 months. Healthcare-associated infections add considerable costs to the delivery of healthcare in Australia, with around 165,000 healthcare-associated infections each year.

However, the incidence of infections is not only a concern due to their direct impact on morbidity and mortality. Infections are also the core reason for antimicrobial use including antibiotics. Australia has one of the highest rates of antibiotic use in the world, with high rates of antibiotic use associated with increasing rates of antibiotic resistance. Antibiotic use has been gradually increasing since 2017 in Australian hospitals participating in surveillance programs. Overuse and inappropriate use of antibiotics in hospitals is a key factor in driving antimicrobial resistance, with nearly one-quarter of the prescriptions assessed found to be inappropriate.

Healthcare associated infections are preventable, with several approaches available to help prevent or significantly reduce their number of HAIs. Since infections are the core reason for antimicrobial use, efforts to prevent, reduce and control their spread helps lower the need for antimicrobials in the first place. The less antimicrobials are used, the less opportunity there is for organisms to develop resistance. Although good antimicrobial stewardship once infections occur is important, more can be done to prevent healthcare associated infections.

GHGO level of support

Grants

• Grants of up to $6 million is available over 2 years from 2023-24
• Maximum grant amount of $3 million in 2023-24
• Maximum grant amount of $3 million in 2024-25
• Maximum amount of $2 million for a single grant
• Up to 100% of eligible project costs (grant percentage)

GHGO important dates

• This program is currently closed
• Register your interest here with GrantHelper

GHGO important details that you will need to know

GHGO assessment criteria

Ref	Criterion	Weighting
1	Project Impact – describe how the project builds upon existing knowledge to progress the area of research and how the research outcomes will contribute to meaningful advances in health outcomes, practice and/or policy in Australia – demonstrate how the views and values of consumers, the community, health providers and/or other end users have informed the proposed research, including how the needs and priorities of consumers (particularly those with lived experience and their carers) have informed the research question – demonstrate the involvement of academic, industry, state/territory, and/or other partners in the project and how their needs and views have informed its conceptualisation, development and planned translation and implementation. – describe how the anticipated outputs will contribute to meaningful advances in health outcomes, practice and/or policy for the priority population – demonstrate how the proposed research focuses on interventions that will be acceptable (e.g. culturally appropriate) to the priority population – demonstrate leadership by, and involvement of, the priority population in the project, and how their needs, views and values have informed its conceptualisation, development and planned implementation.	40%
2	Project Methodology – the research question and the proposed approach for addressing it, including (as appropriate) tools and techniques, participants (e.g. diversity of participants), interventions, controls, statistical approaches, and strategies for data collection and use – how consumers will be involved in the proposed research, including their contributions throughout the life of the project – arrangements for project governance and oversight to support its successful delivery – appropriate milestones, performance indicators and timeframes. – provide details of the trial design – specify and justify recruitment targets (including targets for ensuring diversity, e.g. by gender) and sample sizes – articulate how the clinical trial design will support advancement of robust clinical trial methodologies and/or protocols – describe how consumers have been involved in the trial design (e.g. its conception, protocol and schedule, participant information, consent forms or videos).	30%
3	Capacity, capability and resources to deliver the project – the research team has an appropriate mix of skills (scientific, project management, etc) to undertake the proposed research – the research team includes individuals that bring diverse experiences and expertise (e.g. across disciplines, genders, cultures, lived experience relevant to the research question, career stages and research sectors) – the research team has the skills, experience and capacity to involve and support consumers (including those with lived experience) in the proposed research, and ensure that this is done appropriately and effectively – the commitment of partners to the project and how they will support (through financial and in-kind contributions) its successful delivery.	30%
4	Overall Value and Risk of the Project – the relative contribution of the outcomes or results you have identified in your Measures of Success statement to the intended outcomes of the grant opportunity, the goal and aims of the Initiative, and the MRFF – the appropriateness of the requested budget (including the value and type of any contributions from partners) to support successful delivery of the project, including whether it is sufficiently detailed and justified and represents value with relevant money – the appropriateness of the risk management plan, including strategies for identifying, documenting, monitoring and reporting on key risks to the completion of the project.	Non-weighted

See the guidelines for full details of the assessment.

GHGO resources

• Source
• Guidelines
• Sample application form
• Sample grant agreement

How do I get the GHGO?

You should read and understand the guidelines.

You need to ensure you are eligible for the funding. Applicants that do not meet all the eligibility criteria outlined above will not be considered.

Successful projects will include all of the following components:

• identification of partners/stakeholders and option for co-design where possible to ensure engagement, collaboration and best project outcomes
• conduct research that delivers against the above objective and those of the Global Health Initiative
• propose novel and/or innovative research and describe how the outcomes of the research will be translated into health benefits for Australians
• a strong rationale for the initial project plan, including how the project will contribute to government targets and broader objectives, with expected outcomes and benefits and how these will be measured
• expected costs and benefits of the project, which must be demonstrated, and can include economic, social, environmental and cultural considerations
• a detailed risk management plan, and any supporting documentation, describing how you propose to monitor, manage and report identified risks including risks that may arise during your project (maximum two pages)
• reporting measures and methodology for ongoing monitoring and evaluation

I need help applying for grants

Our Insights showcase some of the grant-winning methods we employ at GrantHelper, and they will help you create a stronger grant application. But no matter how well prepared you are, winning grants takes time—something we know many business owners and directors just don’t have. And that’s why we’re here to help.

• Check out our How to Prepare Before You Apply insight to help you reduce the stress levels when you apply for a grant.
• Check out How to write a successful grant application to learn some time-saving tips to make the grant writing process easier.

GrantHelper can assist with your organisation’s next grant application, no matter what stage of the funding journey you’re at.

Our in-depth eBook is the single most valuable resource you will find that helps organisations to truly understand how to win government grants.

Is your business eligible for this government grant?

Or perhaps you’re not sure and want to know more?

GrantHelper offers a range of government grant services, helping businesses of all sizes to discover, apply for, and win the best grant opportunities. We can help you with anything from finding the right grants, to writing your application, formulating an ongoing grant strategy, and more.

Get started now by filling in the form below, or tap the ‘Book a Discovery Call’ button to schedule a no-obligation virtual meeting with an experienced government grants consultant.

Prefer to talk? Call 0409 478 850 now for a no-obligation discussion. We’re here to help your business better understand grants, submit your best possible application, and get you in the winners’ circle.

Check out some of the clients we’ve helped and what they had to say about us.